Dissection of a circulating and intrahepatic CD4 +Foxp3 + T-cell subpopulation in chronic hepatitis B virus (HBV) infection: A highly informative strategy for distinguishing chronic HBV infection states

Journal of Infectious Diseases

Volumn 205, Issue 7, 2012, Pages 1111-1120

  Zhang, Mengjun ^a   Zhou, Jijun ^a   Zhao, Tingting ^a   Huang, Guangyu ^a   Tan, Yulong ^a   Tan, Shun ^a   Fu, Xiaolan ^a   Niu, Wei ^a   Meng, Gang ^a   Chen, Xiaoling ^a   Shang, Xiaoyun ^a   Liu, Dong ^a   Ni, Bing ^a   Wang, Li ^a   Wu, Yuzhang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CD4 ANTIGEN; HEPATITIS B CORE ANTIGEN; HLA DR ANTIGEN; HLA DR9 ANTIGEN; INTERLEUKIN 17; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; VIRUS DNA;

ACUTE LIVER FAILURE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLELE; ANTIGEN SPECIFICITY; ARTICLE; ASYMPTOMATIC INFECTION; CD4+ T LYMPHOCYTE; CELL EXPANSION; CHRONIC LIVER FAILURE; CONTROLLED STUDY; DISEASE CARRIER; DISEASE SEVERITY; HEPATITIS B; HUMAN; HUMAN CELL; LIVER HISTOLOGY; LIVER INJURY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN SECRETION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

CD4-POSITIVE T-LYMPHOCYTES; DNA, VIRAL; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; VIRAL LOAD; VIREMIA;

EID: 84863275020     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis011     Document Type: Article

References (32)

1. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005; 5:215-29. (Pubitemid 40364823)
2. Bertoletti A, Gehring AJ. The immune response during hepatitis B virus infection. J Gen Virol 2006; 87:1439-49. (Pubitemid 43827198)
3. Peng G, Li S, Wu W, Sun Z, Chen Y, Chen Z. Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection. Immunology 2008; 123:57-65. (Pubitemid 350255997)
4. Yang G, Liu A, Xie Q, et al. Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B. Int Immunol 2007; 19:133-40. (Pubitemid 46179008)
5. Xu D, Fu J, Jin L, et al. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 2006; 177:739-47. (Pubitemid 43939189)
6. Franzese O, Kennedy PT, Gehring AJ, et al. Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection. J Virol 2005; 79:3322-8. (Pubitemid 40327921)
7. Stoop JN, van der Molen RG, Baan CC, et al. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 2005; 41:771-8. (Pubitemid 40462939)
8. Barboza L, Salmen S, Goncalves L, et al. Antigen-induced regulatory T cells in HBV chronically infected patients. Virology 2007; 368:41-9. (Pubitemid 47610682)
9. Tran DQ, Ramsey H, Shevach EM. Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 2007; 110:2983-90. (Pubitemid 350006952)
10. Miyara M, Yoshioka Y, Kitoh A, et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009; 30:899-911.
11. Chinese Medical Society of Hepatology, Infectious Diseases, and Parasitology. Management scheme of diagnostic and therapy criteria of viral hepatitis. Zhonghua Gan Zang Bing Za Zhi 2000; 324-9.
12. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991; 13:372-4.
13. Ebinuma H, Nakamoto N, Li Y, et al. Identification and in vitro expansion of functional antigen-specific CD25+ FoxP3+ regulatory T cells in hepatitis C virus infection. J Virol 2008; 82:5043-53. (Pubitemid 351657064)
14. Bonertz A, Weitz J, Pietsch DH, et al. Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma. J Clin Invest 2009; 119:3311-21.
15. Feng IC, Koay LB, Sheu MJ, et al. HBcAg-specific CD4+CD25+ regulatory T cells modulate immune tolerance and acute exacerbation on the natural history of chronic hepatitis B virus infection. J Biomed Sci 2007; 14:43-57.
16. Diepolder HM, Jung MC, Keller E, et al. A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B. Clin Exp Immunol 1998; 113:244-51.
17. Billerbeck E, Blum HE, Thimme R. Parallel expansion of human virus-specific FoxP3-effector memory and de novo-generated FoxP3+ regulatory CD8+ T cells upon antigen recognition in vitro. J Immunol 2007; 179:1039-48.
18. Walker LS, Chodos A, Eggena M, Dooms H, Abbas AK. Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J Exp Med 2003; 198:249-58. (Pubitemid 36992178)
19. Taams LS, Vukmanovic-Stejic M, Smith J, et al. Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. Eur J Immunol 2002; 32:1621-30. (Pubitemid 34679150)
20. Booth NJ, McQuaid AJ, Sobande T, et al. Different proliferative potential and migratory characteristics of human CD4+ regulatory T cells that express either CD45RA or CD45RO. J Immunol 2010; 184:4317-26.
21. Tomura M, Honda T, Tanizaki H, et al. Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in mice. J Clin Invest 2010; 120:883-93.
22. Kondo Y, Kobayashi K, Ueno Y, et al. Mechanism of T cell hyporesponsiveness to HBcAg is associated with regulatory T cells in chronic hepatitis B. World J Gastroenterol 2006; 12:4310-7. (Pubitemid 44194522)
23. Voo KS, Peng G, Guo Z, et al. Functional characterization of EBV-encoded nuclear antigen 1-specific CD4+ helper and regulatory T cells elicited by in vitro peptide stimulation. Cancer Res 2005; 65:1577-86. (Pubitemid 40270188)
24. Nagato T, Kobayashi H, Yanai M, et al. Functional analysis of birch pollen allergen Bet v 1-specific regulatory T cells. J Immunol 2007; 178:1189-98. (Pubitemid 46095193)
25. Meng XQ, Chen HG, Ma YL, Liu KZ. Influence of HLA class II molecules on the outcome of hepatitis B virus infection in population of Zhejiang Province in China. Hepatobiliary Pancreat Dis Int 2003; 2:230-3.
26. Li S, Jones KL, Woollard DJ, et al. Defining target antigens for CD25+ FOXP3 + IFN-gamma- regulatory T cells in chronic hepatitis C virus infection. Immunol Cell Biol 2007; 85:197-204. (Pubitemid 46701422)
27. Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188:287-96. (Pubitemid 28357757)
28. Yu P, Gregg RK, Bell JJ, et al. Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen. J Immunol 2005; 174:6772-80. (Pubitemid 40705640)
29. Kapp JA, Honjo K, Kapp LM, Goldsmith K, Bucy RP. Antigen, in the presence of TGF-beta, induces up-regulation of FoxP3gfp+ in CD4+ TCR transgenic T cells that mediate linked suppression of CD8+ T cell responses. J Immunol 2007; 179:2105-14.
30. Antonio B, Mala KM. Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection? Curr Opin Immunol 2000; 12:403-8.
31. Matteo I, Giovanni S, Zaverio MR, Luca GG. HBV pathogenesis in animal models: recent advances on the role of platelets. J Hepatol 2007; 46:719-26.
32. Zhang Z, Shuye Zhang SY, Zou ZS, et al. Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients. Hepatology 2011; 53:73-85.